BioCentury
ARTICLE | Clinical News

Ropinirole: Phase II started

September 16, 2013 7:00 AM UTC

Hisamitsu began a placebo-controlled, Japanese Phase II trial to evaluate once-daily HP-3000 in patients with moderate to severe idiopathic RLS. Hisamitsu plans to start a Phase III trial of HP-3000 f...